Sign In
Buy EW
$86.00
-1.66 (-1.89%)
At Close: Jun 03, 2026
GLP-1 wars: Lilly's FDA-approved oral weight-loss pill puts Novo Nordisk's Wegovy franchise under fresh pressure
09:12am, Thursday, 02'nd Apr 2026
Foundayo launches on April 6 at the same price as Novo's pill, threatening to reshape the $50 billion obesity drug market before Novo's first-quarter...
Smart automation bots and the future of forex trading
07:10am, Thursday, 02'nd Apr 2026
The forex market now turns over $9.6 trillion every single day. That figure, confirmed by the Bank for International Settlements in its 2025 Triennial...
Boston Common Asset Management LLC Acquires 9,028 Shares of Edwards Lifesciences Corporation $EW
04:34am, Tuesday, 31'st Mar 2026
Boston Common Asset Management LLC boosted its holdings in Edwards Lifesciences Corporation (NYSE: EW) by 6.7% in the fourth quarter, according to the company in its most recent 13F filing with the SE
Two Year Data on Edwards Lifesciences' EVOQUE System Continue to Demonstrate Significant and Sustained Patient Benefits
10:00am, Monday, 30'th Mar 2026
NEW ORLEANS--(BUSINESS WIRE)--Edwards Lifesciences (NYSE: EW) today announced new data on the EVOQUE transcatheter tricuspid valve replacement (TTVR) system at the American College of Cardiology Annua
ERBA Diagnostics (OTCMKTS:ERBA) & Edwards Lifesciences (NYSE:EW) Head to Head Review
02:43am, Saturday, 28'th Mar 2026
Edwards Lifesciences (NYSE: EW - Get Free Report) and ERBA Diagnostics (OTCMKTS:ERBA - Get Free Report) are both medical companies, but which is the superior investment? We will compare the two busine
Brevan Howard Capital Management LP Has $3.60 Million Stake in Edwards Lifesciences Corporation $EW
03:44am, Tuesday, 17'th Mar 2026
Brevan Howard Capital Management LP lowered its stake in shares of Edwards Lifesciences Corporation (NYSE: EW) by 41.7% during the third quarter, according to the company in its most recent disclosure
Edwards Lifesciences: More Appeal For The Heart
09:04am, Monday, 16'th Mar 2026
Edwards Lifesciences delivered 11% revenue growth in 2025, driven by robust TAVR and accelerating TMTT businesses. Edwards Lifesciences guides for 8-10% sales growth and adjusted EPS of $2.90-$3.05 in
Edwards Lifesciences Corporation $EW Stock Position Lifted by Banco Bilbao Vizcaya Argentaria S.A.
04:56am, Monday, 16'th Mar 2026
Banco Bilbao Vizcaya Argentaria S.A. lifted its position in Edwards Lifesciences Corporation (NYSE: EW) by 9.2% in the undefined quarter, according to the company in its most recent filing with the Se
Banque Transatlantique SA Has $2.91 Million Position in Edwards Lifesciences Corporation $EW
03:52am, Saturday, 14'th Mar 2026
Banque Transatlantique SA trimmed its position in Edwards Lifesciences Corporation (NYSE: EW) by 32.6% during the third quarter, according to the company in its most recent 13F filing with the Securit
Edwards Lifesciences Stock Up 22.1% in a Year: What's Driving It?
09:11am, Friday, 13'th Mar 2026
EW shares jump 22.1% in a year as growth in TMTT and strong adoption of PASCAL, EVOQUE and SAPIEN technologies fuel momentum.
Edwards Lifesciences Corporation (EW) Presents at Leerink Global Healthcare Conference 2026 Transcript
12:02pm, Wednesday, 11'th Mar 2026
Edwards Lifesciences Corporation (EW) Presents at Leerink Global Healthcare Conference 2026 Transcript
Edwards Lifesciences Corporation (EW) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
01:30pm, Tuesday, 10'th Mar 2026
Edwards Lifesciences Corporation (EW) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
5 Medical Instruments Stocks to Buy Amid Huge Short-Term Price Upside
10:36am, Tuesday, 10'th Mar 2026
ISRG, GMED, EW, ALC and IRMD show strong short-term upside as AI tools, acquisitions and new product pipelines fuel growth.
Edwards Lifesciences Corporation (NYSE:EW) Receives Consensus Recommendation of “Moderate Buy” from Analysts
02:26am, Tuesday, 10'th Mar 2026
Shares of Edwards Lifesciences Corporation (NYSE: EW - Get Free Report) have been assigned an average recommendation of "Moderate Buy" from the twenty-seven brokerages that are presently covering the
Edwards Lifesciences Corporation $EW Shares Acquired by Elo Mutual Pension Insurance Co
04:29am, Tuesday, 03'rd Mar 2026
Elo Mutual Pension Insurance Co lifted its stake in shares of Edwards Lifesciences Corporation (NYSE: EW) by 39.9% during the third quarter, according to its most recent disclosure with the Securities
